Voyager Therapeutics Welcomes Nathan Jorgensen as Chief Financial Officer

Thursday, 13 June 2024, 12:12

Voyager Therapeutics, Inc. announced the appointment of Nathan Jorgensen as Chief Financial Officer starting July 8, marking a significant leadership change within the company. Jorgensen brings extensive expertise in financial management to drive strategic growth. The move is expected to have a notable impact on the financial landscape of Voyager Therapeutics.

LivaRava Finance Meta Image — Voyager Therapeutics Welcomes Nathan Jorgensen as Chief Financial Officer

Voyager Therapeutics Appoints Nathan Jorgensen As New CFO

(RTTNews) - Voyager Therapeutics, Inc. (VYGR) Thursday said it appointed Nathan Jorgensen as Chief Financial Officer, effective July 8.

Most recent addition to the executive team.

Key Points:

Nathan Jorgensen appointed as CFO
Effective July 8, 2021
Expected impact on strategic growth

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.

Voyager Therapeutics Appoints Nathan Jorgensen As New CFO

Key Points:

Related posts